Near infrared transillumination imaging of breast cancer with vasoactive inhalation contrast by Dixit, Sanhita S. et al.
Near infrared transillumination imaging of 
breast cancer with vasoactive inhalation contrast 
Sanhita S. Dixit,
1 Hanyoup Kim,
1,2 Christopher Comstock,
3,4 and Gregory W. Faris
1,* 
1Molecular Physics Laboratory, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA 
2Currently with Biosystems Research and Development, Sandia National Labs, 7011 East Ave. MS9292,  
Livermore CA 94550, USA 
3Moores UCSD Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92093, USA 
4Currently with the Memorial Sloan-Kettering Cancer Center.300 East 66th Street, New York, NY 10065, USA 
*gregory.faris@sri.com 
Abstract: Inhalation of vasoactive gases such as carbon dioxide and oxygen 
can provide strong changes in tissue hemodynamics. In this report, we 
present a preliminary clinical study aimed at assessing the feasibility of 
inhalation-based contrast with near infrared continuous wave 
transillumination for breast imaging. We describe a method for fitting the 
transient absorbance that provides the wavelength dependence of the optical 
pathlength as parametrized by tissue oxygenation and scatter power as well 
as the differential changes in oxy- and deoxy-hemoglobin. We also present a 
principal component analysis data reduction technique to assess the 
dynamic response from the tissue that uses coercion to provide single 
temporal eigenvalues associated with both oxy- and deoxy-hemoglobin 
changes. 
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1. Introduction 
The development of complementary imaging modalities for imaging breast cancer has been an 
important priority for the imaging community. Specifically, the ability of near infrared (NIR) 
light, 600-1000 nm, to image breast tissue has led to significant advances, including the 
development of optical tomography [1–5] and diffuse optical imaging and spectroscopy [6–8] 
modalities. NIR imaging lends itself easily to the use of endogenous contrast due to the strong 
absorption of oxy- (HbO2) and deoxy- (Hb) hemoglobin in blood. In this wavelength window, 
the absorption due to water is low, enabling instruments to capture contrast due to these blood 
chromophores. In breast tissue, where the vasculature is not dense, the presence of tumors 
results in increased vasculature to feed the growing tumor tissue [9]. This vasculature is often 
chaotic in structure and can be leaky in nature. It has been postulated that exogenous 
vasoactive contrast agents such as carbogen gas (95% O2 and 5% CO2) could provide contrast 
when coupled with a NIR imaging system to image breast tumors. 
Our laboratory has been investigating the use carbogen gas as a contrast agent to image 
cancer using a differential NIR imaging method. In the differential imaging approach, 
baseline images are acquired during inhalation of room air. Logarithms of these images are 
then subtracted from logarithms of the images acquired during the inhalation of the vasoactive 
gas to produce the differential images used in all of our studies. Animal model studies from 
our group using this approach established the viability of this hypothesis [10]. The 
development of a continuous wave (CW) NIR imaging instrument designed to image breast 
tissue has also been reported [11]. In that report we detail various aspects of the instrument 
design and gas delivery protocols with images of the palm. This study revealed several 
important trends. We noted that the Bain’s circuit provided more efficient delivery of 
carbogen gas, the use of air + 5% CO2 and 95% O2 + 5% N2 was well tolerated, and the effect 
of carbogen appeared to indicate a vasoconstriction effect. 
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function of carbogen inhalation and compression. We also show data from imaging diseased 
breast tissue using carbogen inhalation to induce contrast. While we have reported early data 
from these studies [12], this account is a detailed compilation of the work. There have been a 
limited number of reports in the literature regarding the effect of vasoactive gas inhalation on 
contrast from breast tissue. An x-ray mammography study reported results on a single subject 
[13] where a signal increase of roughly 15% was observed between the first air and oxygen 
period. Recent reports using magnetic resonance guided near-infrared imaging of healthy 
breast tissue revealed that carbogen acts as a vasodilator [14]. A follow-up study by the same 
authors on a pilot clinical investigation involving two cancer subjects was indicative of a 
greater correlation of the total hemoglobin to the carbogen gas stimulus in healthy versus 
tumor tissue [15]. Inhalation based vasoactive imaging has also been reported in a clinical 
setting using bold MRI [16] on various carcinomas. 
2. Experimental details 
Instrument design 
The design of the transillumination-based NIR instrument has been detailed in a previous 
publication from our laboratory [11]. Spot paddles for x-ray mammography (AR Custom 
Medical Products, Commack, New York) were used to support the breast for imaging in 
combination with an NIR light source and a CCD camera. Five wavelengths were available 
for the transillumination measurements with nominal values of 690, 735, 810, 850, and 940 
nm. The LED illuminators (Epitex, Kyoto, Japan) had the following center wavelengths as 
measured by a spectrometer (Ocean Optics, Dunedin, Florida): 680, 734, 813, 830, and 933 
nm. These wavelengths were stable to within 2 nm for measurements lasting up to 25 min. 
The measured wavelengths were used in calculations as described in Section 3. The 
instrument was assembled on an optical rail and was placed on the C-arm of a stereo-tactic 
breast biopsy table as shown in Fig. 1. The arm of the table could be rotated to allow different 
imaging positions such as craniocaudal (CC), mediolateral oblique (MLO), and mediolateral 
(ML). Masks were prepared using black paper to prevent light leakage through the spot 
paddles from regions that did not touch the breast tissue as shown in Fig. 1(c). Phantom 
measurements indicated no light transmission through these masks. The camera (Apogee 
Instruments) was tilted during image acquisition to allow imaging close to the chest wall; in 
this configuration, the imaging system could be raised until the spot paddles touched the 
bottom of the opening in the table. Mild compression, on the order of 1 pound force, was 
applied to the breast to minimize motion during the imaging experiments. The load cell, 
which measured the compression force, was connected to the paddle closer to the camera. 
Labview software was used to automate data collection. Phantom measurements were 
routinely performed in the clinic prior to imaging runs to verify software performance. In 
some cases, imaging was also performed in the sitting position when the stereo-tactic table 
was unavailable. In these cases the imaging system was supported by a tripod. We have set 
the smallest exposure time to default at 0.05 ms in the imaging software. We have been able 
to get signal in our images with exposure times as low as 0.06 ms for 810 nm and 850 nm 
when tissue transmission is good. 
Breathing circuit 
Two types of breathing circuits were used in this study: a non-rebreathing circuit and a Bain’s 
circuit. Details for each type of circuit have been reported [11]. Prior to data collection a 
capnometer and pulse oximeter (Tidal Wave® Hand-held Capnograph) recorded baseline 
values of end tidal CO2, inspired CO2, blood saturation (SpO2) and pulse rate values. Samples 
of inhaled and exhaled air were recorded by the capnometer via an airway adapter on the 
mouthpiece. This mouthpiece was used to deliver room air or carbogen to the volunteer during 
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is 3% although the capnometer can read higher values for end tidal CO2%. Room air was 
inhaled through the mouthpiece for a time interval of two minutes after which the breathing 
circuit tube was manually connected to the mouthpiece adapter for a total carbogen inhalation 
time of two minutes. The carbogen gas flow rate was maintained at or close to 15 liters per 
minute using a regulator during the entire two minutes in the data reported here. After the end 
of the two minute gas delivery, the breathing circuit tube was removed from the mouthpiece 
adapter and room air was inhaled for a final two minutes. The carbogen gas flow was turned 
on before the tube was attached to the mouthpiece adapter and turned off after the tube was 
disconnected from the mouthpiece adapter. This ensured smooth delivery of the gas to the 
volunteer. A typical inhalation cycle lasted a total of six minutes; 2 min (air)/2 min 
(carbogen)/2 min (air), during which imaging is performed continuously. A nose clip was 
used during the entire imaging run to ensure that the volunteer inhaled only through the 
mouthpiece. A typical imaging run involved collection of background images for each 
wavelength followed by data collection during a gas inhalation cycle. During the gas 
inhalation cycle, typically 15 frames per wavelength were collected for each gas, although this 
number may increase to about 20 frames if we get lower exposure times for a subject because 
the transmission through the breast tissue is strong. Medical grade carbogen gas was used in 
the study and was supplied by Airgas. 
Clinical aspects 
All imaging was performed in the radiology department of the Moores Cancer Center at the 
UCSD School of Medicine under appropriate consent. The image protocol was approved by 
both the UCSD Institutional Review Board (IRB) and the IRB of SRI International. The 
instrument was transported by plane from Menlo Park to San Diego for the imaging sessions. 
Table 1 summarizes the total number of subjects imaged in this study at UCSD. 
Table 1. Number of Subjects Imaged in this Study. 
Tissue Type  Number of Subjects  Type of Run (Test/Compression/Inhalation) 
Healthy  17  7 Runs: Preliminary Tests / Imaging Only 
7 Runs: Inhalation 
3 Runs: Only Compression 
Fibroadenoma 4  Inhalation 
Cancer 6  Inhalation 
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Fig. 1. (a) The NIR imaging instrument placed on the C-arm of a stereo-tactic breast biopsy 
table. The red arrows indicate the position of the breast during imaging. (b) Top view as seen 
from the table platform. The space between the two spot paddles localizes the breast tissue. (c) 
A schematic of the front face of the spot paddles. The white region is the only transparent zone 
on the paddle. This zone interfaces with the breast tissue. 
3. Data analysis 
We convert our multi-wavelength images to images of deoxyhemoglobin and oxyhemoglobin 
based on a differential pathlength analysis [17] similar to our previous studies [10,11]. In this 
case the transient intensity IT is related to the baseline intensity IB according to 
    exp
ii i i
TB a I IL
         (1) 
where 
i
a
   and 
i L
  are the change in the absorption coefficient and the optical pathlength, 
which is equal to the product of the source-detector separation distance and the differential 
pathlength factor. The superscripts for all variables denote that the parameters are for 
wavelength λi. We assume that the changing absorbance is due primarily to changes in the 
concentrations of deoxyhemoglobin and oxyhemoglobin, Δ[Hb] and Δ[HbO2], respectively. 
This is a good assumption because the inhalation protocol primarily influences blood vessels 
and blood oxygenation. In this case 
  a
i  ln(10){Hb
i [Hb]HbO2
i [HbO2]}   (2) 
where 
i
Hb
   and 
2
i
HbO
  are the (base 10) absorption coefficients at wavelength λi. We will ratio 
all pathlength factors to the pathlength factor at a single wavelength, 813 nm. Although our 
instrumentation supports measurements at 5 wavelengths, we have omitted the 933 nm images 
from our analysis because first, the 933 nm wavelength did not always provide good images 
and second, the absorbance portion of the wavelength dependence of the optical pathlengths 
for the other wavelengths are primarily influenced by deoxyhemoglobin and oxyhemoglobin, 
while 933 nm is also influenced by water and fat, which complicates the derivation of optical 
pathlengths. For a typical data set involving 50 images at each of 5 wavelengths, we have 200 
measurements for each pixel. For this typical data set, there are 103 unknown values for each 
pixel: the 3 optical pathlength ratios at that pixel and 50 values each for Δ[Hb] and Δ[HbO2]. 
Thus we can potentially determine the 103 unknowns from the 200 measurements. For any 
given set of values for the optical pathlengths, we can calculate the Δ[Hb] and Δ[HbO2] 6 
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the optical pathlength ratios until the root mean square variation of the estimates of Δ[Hb] and 
Δ[HbO2] are minimized; i.e., until all possible estimates are very close together. To improve 
this convergence we make two modifications. First, we omit the 813 nm / 830 nm wavelength 
pair because they respond quite similarly to changes in Δ[Hb] and Δ[HbO2]. Second, instead 
of fitting three parameters (the three optical pathlength ratios), we fit two parameters, the 
tissue oxygenation and scatter power. We note that the optical pathlength at a single 
wavelength can be written as [18] 
 
3
2
i
i
i
s
a
L









   (3) 
where µa is the absorption coefficient,  s  is the reduced scattering coefficient, and ρ is the 
pathlength without scattering. If we also assume that the only significant chromophores 
contributing to the wavelength dependence of the optical pathlength are deoxyhemoglobin and 
oxyhemoglobin, we can write µa as 
 
2 2 ln(10){ [ ] [ ]}
i ii
aH b HbO Hb HbO
        (4) 
We can rewrite Eq. (4) as 
 
2 ln(10){(1 ) }[ ]
i ii
aH b t o t HbO x xH b
         (5) 
where x is the oxygenation (x = [HbO2]/[Hbtot]) and [Hbtot] is the total hemoglobin 
concentration. 
The wavelength dependence of  s  can be modeled using a scatter power model [19] 
 
SP
s A  
      (6) 
where A is a constant and SP the scatter power. Using Eqs. (3), (5), and (6), we can write the 
optical pathlengths as 
 
0 0
2
0
2 0
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i i
SP i
Hbs HbO i
Hb HbO
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L xx
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 
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 
   (7) 
where λ0 = 813 nm. Thus we can fit the optical pathlength ratios based on two unknowns, 
oxygenation (x) and scatter power (SP). Thus the differential imaging analysis can provide 
information not only on dynamic properties Δ[Hb] and Δ[HbO2], but also on the static tissue 
properties (oxygenation and scatter power). As is typical for differential pathlength analysis, 
we assume that the changes Δ[Hb] and Δ[HbO2] are not large enough to change the optical 
pathlength values. 
Finally, to better understand the temporal variations in the data as a result of the carbogen 
inhalation, we process the ∆[Hb] and ∆[HbO2] images using a principal component analysis 
algorithm [20–22]. Briefly, the method involves the subtraction of a mean image from an 
image stack. Thus, if there are t images with i rows and j columns then, 
 
*(, ,) (, ,) () I ijt Iijt It     (8) 
Each image in the resulting stack of mean-subtracted images is transformed into a one-
dimensional vector with ij   elements. The covariance of this new matrix 
*(, ) Iij t   is 
computed, followed by the computation of the eigenvalues, temporal eigenvectors and spatial 
eigenimages. Each temporal eigenvector is a linear combination of the individual pixel time 
series and each spatial eigenimage is a linear combination of the reconstructed images. The 
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original data can be recovered by summing the eigenvalue-temporal eigenvector-eigenimage 
products. No information is lost in this transformation [23]. The temporal eigenvectors are 
uncorrelated because they are orthogonal. This is because the covariance matrix is symmetric. 
Finally, note that the temporal and spatial eigenvectors corresponding to the largest 
eigenvalues correspond to the largest variations in the image set. Also, to understand the 
information presented in a given eigenvalue set, it should be noted that the temporal 
eigenvector indicates the temporal evolution of each pixel in the corresponding spatial 
eigenimage. 
We have used three software packages for data analysis. In the first step, ImageJ is used to 
crop the image, calculate images of ΔμaL at 680, 734, 813, and 830 nm using Eq. (1), and bin 
the processed images to reduce the image size from 512 by 512 to 128 by 128. When any raw 
pixels are saturated, the processed pixels are set to not-a-number to exclude them from the 
subsequent pathlength ratio calculation. In the second step, we used the Igor Pro graphing and 
data analysis package to convert the images of ΔμaL at four wavelengths to images of 
∆[HbO2]*L
813 and ∆[Hb]*L
813 in units of mM*cm as well as images for oxygenation and 
scatter power using Eqs. (2) and (7). The tissue oxygenation and scatter power at each pixel 
are varied until the root mean square estimates of Δ[Hb] and Δ[HbO2] are minimized. 
Although the optical pathlength ratios or oxygenation and scatter power values should not 
change significantly over a spatial distance of a single pixel, we performed fits at every pixel 
in order to gain information of the variability in this analysis. An example of the variability 
may be found in the histograms for the optical pathlength ratios and the oxygenation and 
scatter power images shown in Fig. 2(c), 2(d), and 2(e). In the final step, MATLAB was used 
to compute the eigenvalues, temporal eigenvectors and the spatial eigenimages. In the present 
analysis, a mean image from the temporal image stack, one each for the ∆[Hb] and ∆[HbO2] 
image sets, is subtracted from each image in that stack following Eq. (8). Next, the mean 
subtracted stacks are concatenated into a single image stack for both ∆[HbO2] and ∆[Hb]. This 
image matrix is then subjected to the PCA analysis as mentioned above. The coercion of the 
mean subtracted ∆[Hb] and ∆[HbO2] images simultaneously through the PCA algorithm 
ensures that the temporal eigenvectors show simultaneous changes for both the ∆[Hb] and 
∆[HbO2] images, that is, there is a single temporal eigenvector for both ∆[Hb] and ∆[HbO2]. 
When PCA is performed on ∆[Hb] and ∆[HbO2] separately, the temporal eigenvectors can 
have similar shapes, but aren’t necessarily associated with each other because the eigenvalues 
can differ. The coercion results in single temporal eigenvector and eigenvalue associated with 
the physiological changes for each eigenimage, whether they be due to the individual 
components,  ∆[Hb] and ∆[HbO2], or their combinations, a change in total hemoglobin, 
∆[HbOtot] = ∆[HbO2] + ∆[Hb], or a pure oxygenation change, i.e., ∆[HbO2] - ∆[Hb]. 
4. Results 
Experiments were performed on healthy subjects to investigate the response of the breast 
tissue to carbogen inhalation. Mild compression to stabilize the breast against motion was a 
part of this study, but compression alone also produces tissue changes. To characterize the 
effect of the compression, data were also collected for the same subjects under steady 
compression. Comparison between the two sets of data revealed a different response from the 
breast tissue for a given subject under steady compression and compression accompanied by 
carbogen gas inhalation. 
As an example, in Figs. 2 and 3, we show the response of healthy breast tissue to carbogen 
inhalation. The tissue was held at a compression load of 0.46 pounds. Data acquisition lasted 
for a total of 6 minutes where each two minute interval consisted of room air, carbogen, and 
room air gases respectively, in that order. Carbogen administration is indicated by the blue 
shaded region in all of the temporal data presented in the figures. 
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Fig. 2. Data during carbogen inhalation for a healthy volunteer. For all time dependent data, the 
region shaded blue shows the period of carbogen inhalation. (a) End tidal and inspired percent 
CO2 from capnometer (capnometer readings are delayed relative to gas changes). (b) Time 
dependence of natural absorbance data, -ln(IT/IB), at four wavelengths (solid lines) at a single 
pixel. (c) Histograms of pathlengths calculated from absorbance data. (d) and (e) Scatter power 
and oxygenation values for each pixel from fitting. The resulting static images are for the entire 
imaged regions after processing each pixel through the analysis methodology presented in 
Section 3. (f) and (g) Time dependence of ∆[HbO2]*L
813 and ∆[Hb]*L
813 in units of mM*cm 
for the same pixel as in (b). There are 5 overlapping traces calculated using combinations of the 
multi-wavelength data in (b) and the pathlengths summarized in (c-e). The mean values of the 
∆[HbO2] and ∆[Hb] data from (d) and (e) were used with the pathlengths in (c-e) to calculate 
absorbance at each wavelength, which are also plotted as the dashed lines in (b); these are only 
partially visible due to the high overlap with the measurements (solid lines). (h) Eigenvalues 
from coerced PCA. Temporal eigenvectors and eigenimages for this data set are shown in Fig. 
3. 
A robust response is noted in Fig. 2(a) for the end tidal CO2% values and the inspired 
CO2% values during carbogen inhalation. There is a lag between the capnometer response and 
the gas changes (blue shaded region). We often find the capnometer data to be delayed 
relative to the gas changes. Part of this delay is due to the fact that the capnometer only 
provides updated readings every 8 seconds. For this data set, the rise in the inspired CO2% 
values had an additional lag beyond the rise in the end tidal CO2% values. The reason for this 
additional lag is not known. The timing of the gas administration (blue shaded regions) is 
reliable in each case reported here. Regardless of the timing shift, the end tidal CO2 values 
show that the carbogen gas is being delivered properly. The change in absorbance for all 4 
wavelengths at a single pixel is shown in Fig. 2(b). From such single pixel data we calculate 
values for the pathlength ratios, scatter power, and oxygenation using the fitting procedure 
detailed in the Experimental Methods section above. The resulting pathlength histogram, 
scatter power image, and oxygenation image for all the pixels are shown in Figs. 2(c), 2(d) 
and 2(e), respectively. The pathlengths are all ratioed to the pathlength at 813 nm. Therefore 
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the trends in the ∆[HbO2] and ∆[Hb] values over the 6 minute time interval calculated for the 
same pixel as Fig. 2(b) using the pathlength factors for that pixel. The PCA eigenvalues are 
shown in Fig. 2(h). 
 
Fig. 3. Temporal eigenvectors and eigenimages from coerced PCA for the data in Fig. 2. The 
first two eigenvalues indicate that the corresponding eigenimages show maximum deviations 
from the mean and also carry signals in response to the gas stimulus. The first set of 
eigenimages indicate a marked increase the ∆[HbO2] values with a corresponding decrease in 
the ∆[Hb] values. The magnitudes of the corresponding eigenvalues are also indicated at the 
bottom of the figure. 
The principal component analysis for this data set revealed strong variations from the 
mean for the first two temporal eigenvectors as evidenced by the large eigenvalues. From the 
plot of the eigenvalues shown in Fig. 2(h), it is clear that the first few eigenvalues carry the 
maximum weight. We typically obtain over 45 eigenvectors for each image set. The 
eigenvectors are ordered according to the size of the eigenvalues. Of these, only the smallest 
10 or so show a white noise structure in the eigenimages as is commonly associated with 
noise. A large number of the temporal eigenvectors appear noisy, but the fluctuations in many 
of them are probably actually changes that are occurring faster than our imaging rate such as 
the cardiac cycle, respiration, movement, and other physiological fluctuations. Multiplication 
of the eigenvalue times the temporal eigenvectors times the ∆[HbO2] or ∆[Hb] eigenimage 
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813 or ∆[Hb]*L
813 in units of mM*cm. Summation of 
all of the components will reproduce the original data set for ∆[HbO2]*L
813 or ∆[Hb]*L
813. 
Typically however, only the first few eigenvalues are associated with the temporal 
eigenvectors that carry a response to the gas inhalation stimulus for a given subject. For the 
data shown in Fig. 2, the first four temporal eigenvectors are shown in the first column of  
Fig. 3; the first four eigenimages for ∆[HbO2] and ∆[Hb] are shown adjacent to the 
corresponding temporal eigenvector. Each temporal eigenvector describes the temporal 
variation of its corresponding spatial eigenimage. It is clear that the first eigenset indicates an 
increase in the ∆[HbO2] values upon the onset of the gas and a corresponding decrease in the 
∆[Hb] values. This is presumably due to the increased oxygen inhaled in the carbogen. The 
second eigenset points to a mild decrease in the values of both ∆[HbO2] and ∆[Hb] during the 
carbogen administration phase. This is expected to be vasoconstriction, possibly also from the 
increased oxygen inhalation. Each eigenimage shows the spatial variation of ∆[HbO2] and 
∆[Hb] corresponding to this associated temporal eigenvector. 
In order to compare the effect of steady compression on the transillumination images 
obtained with this instrument, compression data were collected for the same volunteer for  
Fig. 2 over a period of 7 minutes and 30 seconds at a load of 0.65 pounds. These data are 
shown in Fig. 4. The pathlength histograms, scatter power image, and oxygenation image are 
shown in Fig. 4(a)–4(c). The first temporal eigenvector and the corresponding spatial 
eigenimages of ∆[HbO2] and ∆[Hb] are shown in Fig. 4(d). In this set, the dominant response 
was noted only from the first eigenvalue. From the plot, it is apparent that after a delay of 
about 150 seconds there is a general trend of increasing ∆[Hb] values and an overall decrease 
in the ∆[HbO2] values. This response is opposite to that seen for inhalation and much smaller 
in size as seen from the first temporal eigenvectors and the corresponding spatial eigenimages 
in Fig. 3. Thus, pure compression without the carbogen inhalation results in a reduction of 
blood oxygenation over time. This is expected to result from reduced circulation under 
compression, leading to less oxygen delivery. We find differences in the pathlength factors 
between carbogen inhalation and compression alone, as seen by comparing Fig. 2(c), 2(d) and 
2(e) with Fig. 4(a), 4(b), and 4(c). The scatter power has extremely low values, essentially 
zero, and the oxygenation is rather low, in the range of 30%. The source of these differences 
is not known. It may be due to the fact that carbogen and compression impact different 
compartments of the circulation vasculature, or the pure compression response may differ 
more strongly from the differential pathlength model than the inhalation response. 
For our data on healthy subjects, we find common trends. First, carbogen inhalation results 
in a stepwise (persistent) increase in oxygenation and a transient decrease in total hemoglobin. 
Second, mild compression without carbogen inhalation leads to a stepwise decrease in 
oxygenation, in essence the opposite response of the dominant response to carbogen and much 
smaller in magnitude. We have two data sets comparing carbogen inhalation with mild 
compression without carbogen inhalation in healthy subjects. The subject with a stronger 
response to carbogen also had a stronger response to compression only. There is intersubject 
variability in the magnitude of the response and relative changes in HbO2 and Hb for 
compression alone. 
#130437 - $15.00 USD Received 21 Jun 2010; revised 17 Jul 2010; accepted 20 Jul 2010; published 27 Jul 2010
(C) 2010 OSA 2 August 2010 / Vol. 1,  No. 1 / BIOMEDICAL OPTICS EXPRESS  304 
Fig. 4. Data acquired for mild compression without gas inhalation for the same subject as  
Figs. 2 and 3. (a), (b), and (c) summarize pathlength ratios as a histogram, scatter power image, 
and oxygenation image, respectively. (d) First four temporal eigenvectors and eigenimages 
from coerced PCA with the corresponding magnitudes for the eigenvalues for this set. 
We also measured the response from breast tissue of subjects with confirmed cases of 
fibroadenomas as per pathology reports provided to the radiologist in this study (Dr. 
Comstock). Data for one such subject are shown in Fig. 5. The capnometer registered efficient 
gas breathing parameters, however, the inspired CO2% and end tidal CO2% values lagged the 
onset of gas delivery. The location of the lesion was not available at the time of data 
collection. Figure 5(a), 5(b), and 5(c) show the pathlength ratio histogram, scatter power 
image and oxygenation image from the fitting analysis performed on the difference 
absorbance data for this set. The scatter power is close to zero over much of the image. Higher 
oxygenation values near the dense vascular bed are observed. In Fig. 5(d), we show the plots 
for the first four temporal eigenvectors with the corresponding ∆[HbO2] and ∆[Hb] 
eigenimage maps. In this set, the first and third temporal eigenvectors carried signatures in the 
carbogen inhalation phase and the first three eigenvalues were the most significant. Again, the 
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values in the entire imaged tissue and a corresponding decrease in the ∆[Hb] values. 
 
Fig. 5. (Media 1) Data from a subject with fibroadenoma. (a), (b), and (c) Pathlength ratio 
histogram, scatter power image, and oxygenation image, respectively. The images in (b) and 
(c) are obtained after analyzing each pixel in the original image according to the methodology 
presented in Section 3. (d) First four temporal eigenvectors and eigenimages from coerced PCA 
with the corresponding magnitudes for the eigenvalues for this set. 
In the ∆[HbO2] and ∆[Hb] image maps for Fig. 5, the vasculature is seen clearly with the 
maximum response seen from this zone. The third temporal eigenvector shown in the third 
row of Fig. 5(d) along with the corresponding ∆[HbO2] and ∆[Hb] image maps shows a 
transient carbogen specific response that has a dominant contribution from the tissue 
vasculature in a section of the tissue imaged. This heterogeneous response from specific zones 
in the tissue may be indicative of varied effects of the gas on different vascular beds in the 
tissue, with regions showing both vasoconstriction and vasodilation. The second and fourth 
temporal eigenvectors do not appear to be associated with the inhalation. Altogether, 4 
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reporting efficient gas inhalation. The data presented in Fig. 5 are for this subject. 
Lastly, we present data from subjects with confirmed cases of cancer. In Fig. 6 we show 
data from a subject where the tumor was located as a large mass in the 12 o’clock position. A 
compression of 0.3 pounds was applied to the tissue. The tumor zone registered in the raw 
transillumination image as a bright zone. Raw transillumination images for this subject are 
shown in Fig. 6(a). Also shown in Fig. 6(b), 6(c), and 6(d) are the pathlength ratio histogram 
and maps for the scatter power and the oxygenation for the absorbance data obtained from the 
fitting analysis method described earlier in this report. The tumor region shows up as a 
reduced oxygenation zone. The scatter power for the tumor zone is also reduced. In this set, 
the capnometer failed to register values when the gas delivery tube was inserted into the 
mouth piece adapter. While the values of blood saturation (SpO2%) and the pulse rate were 
measured, it was difficult to ascertain how efficient the carbogen delivery was to this subject. 
Nevertheless, the consistent saturation of the SpO2% value during the carbogen inhalation 
phase, coupled with the marked increase in the transmitted intensity from the breast during 
carbogen inhalation, points to sufficient carbogen inhalation of the carbogen gas by the 
subject. Finally, we show the first six temporal eigenvectors along with their corresponding 
∆[HbO2] and ∆[Hb] image maps in Fig. 6(e). Of these, the first, fourth and sixth vectors 
showed a response associated with the carbogen inhalation phase. Again, the first temporal 
eigenvector indicates an increase in the ∆[HbO2] values and a decrease in the ∆[Hb] values 
with a marked decrease in the tumor region. The fourth temporal eigenvector along with the 
heme maps, shows yet again a response from the vasculature where a decrease is observed in 
the ∆[HbO2] values in the area surrounding a large blood vessel and an increase in the tumor 
zone during carbogen inhalation. Finally, the sixth temporal eigenimage shows an increase in 
fluctuation associated with the carbogen inhalation, with a dominant response from the tumor 
zone. The nature of these fluctuations is not understood. 
Lastly, we show another data set where the subject has a diagnosed infiltrating ductal 
carcinoma. The capnometer registered efficient carbogen delivery and inhalation by the 
subject. There was some light leakage in this data set so the images have been cropped to 
process zones that were not affected by the light leakage significantly. Only the scatter power 
and oxygenation images, together with the pathlength histogram, are shown for this set in  
Fig. 7. The zone at the base of the image shows a markedly reduced oxygenation. The location 
of this zone corresponds to a tumor location from the pathology report that was very close to 
the chest wall. 
Altogether, six cancer subjects were imaged in this study. Two imaging runs resulted in 
localized zones clearly visible in the inhalation data, which corresponded to the location of the 
lesions detailed in the pathology report. The other four data sets had problems that made 
analysis difficult, including a patient coughing throughout the measurements, capnometer 
failure and no dominant temporal eigenvector, strong light leakage, and LED misfiring. We 
note that our instrument was our first generation clinical device, and an improved instrument 
should have much better clinical results. Problems with light leakage and LED misfiring have 
already been corrected. Automated gas administration will further improve reliability. 
Excessive coughing may require rescheduling the imaging. 
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Fig. 6. Data from subject with invasive carcinoma with mixed ductal and lobular features. (a) 
Raw transillumination images at 680, 734 and 813 nm acquired during air inhalation without 
any image processing are shown. (b), (c), and (d) pathlength histogram, scatter power imaging 
and oxygenation image, respectively obtained by analyzing the signal at each pixel. (e) The 
first six temporal eigenvectors and eigenimages from coerced PCA. The corresponding 
eigenvalues are also indicated. A video file showing the temporal dependence of ∆[HbO2]*L
813 
and  ∆[Hb]*L
813 in units of mM*cm (media 1) shows the onset of carbogen inhalation 
stimulating a sharp rise in oxygenation and fluctuations in the tumor region and the blood 
vessel at the top of the image. 
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Fig. 7. Pathlength histogram, scatter power image, and oxygenation image for subject with 
infiltrating ductal carcinoma. 
5. Conclusions 
The measurements reported in this study provide a description of the response of the 
vasculature in various types of breast tissue under the effect of compression and inhalation of 
carbogen gas. Compression alone results in a persistent change in oxygenation similar in 
shape to compression plus inhalation, but much smaller in magnitude and opposite in sign. 
We conclude that NIR CW transillumination based measurements can provide unique 
information on the vascular response of breast tissue in response to vasoactive gas inhalation. 
We present a method for analysis of optical parameters based on the transient response to the 
gas inhalation, producing static images of oxygenation and scatter power from the resulting 
pathlength factors as well as dynamic images for ∆[HbO2] and ∆[Hb]. We use coerced 
principal component analysis for the combined ∆[HbO2] and ∆[Hb] images to determine 
eigenvectors from the data sets corresponding to different types of vascular response. The 
dominant gas-dependent response includes a stepwise (persistent) increase in oxygenation and 
a transient response that shows variation between individuals and tissue type. We do not 
currently understand the physiological source of the persistent or transient responses and more 
study will be required to better understand this behavior. The method generally shows large 
contrast for cancer, but the number of subjects is relatively small and the interpersonal 
variation is not well understood. More study is required to better understand the behavior of 
this imaging method and its value for cancer imaging. 
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